As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

Additional images and video build on an earlier analysis, which the Pentagon has disputed, showing Precision Strike Missiles, ...

A little more than a decade ago, Nate Eller was an standout student at Twin Hills Middle School in Sebastopol. Today, he’s an ...

Across Africa, Gen Z–led protests are redefining political engagement. But can this new wave of activism move beyond ...

On April 3, the White House released details of its defense budget request for FY 2027. Seamus Daniels unpacks the $1.5 ...

Navigating the Nasdaq Correction: Top AI Stocks to Buy First The Nasdaq Composite has faced a sharp correction this year, ...

Artemis II splashdown live updates: Crew capsule hits water as rescue teams rush to check on astronauts - NASA hailed a ...

India’s digital twin breakthroughs in healthcare—from AI lung models to cardiac and oncology simulations—are redefining precision medicine.